Literature DB >> 8473453

A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception.

P C Ho1, M S Kwan.   

Abstract

A prospective randomized study was conducted at the Family Planning Association of Hong Kong to compare the efficacy of the Yuzpe regimen and levonorgestrel (0.75 mg for two doses 12 h apart) in post-coital contraception. A total of 424 subjects were recruited into the Yuzpe group and 410 subjects into the levonorgestrel group; 77 subjects in the Yuzpe group and 79 subjects in the levonorgestrel group had further acts of intercourse during the treatment cycle. Fifteen pregnancies (3.5%) occurred in the Yuzpe group and 12 pregnancies (2.9%) in the levonorgestrel group. After excluding the patients who had further acts of intercourse, the failure rates in the Yuzpe group and the levonorgestrel group were 2.6 and 2.4% respectively. The incidence of nausea, vomiting and fatigue in the Yuzpe group was significantly higher than those in the levonorgestrel group. We conclude that levonorgestrel is an effective drug for post-coital contraception with a lower incidence of side-effects than the Yuzpe regimen.

Entities:  

Keywords:  Asia; Comparative Studies; Contraception; Contraceptive Agents, Estrogen--administraction and dosage; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents--administraction and dosage; Demographic Factors; Developing Countries; Eastern Asia; Ethinyl Estradiol--administraction and dosage; Family Planning; Fertility; Fertility Control, Postcoital; Fertility Measurements; Hong Kong; Levonorgestrel--administraction and dosage; Norgestrel--administraction and dosage; Population; Population Dynamics; Pregnancy Rate; Prospective Studies; Research Methodology; Studies

Mesh:

Substances:

Year:  1993        PMID: 8473453     DOI: 10.1093/oxfordjournals.humrep.a138057

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  34 in total

Review 1.  [Emergency contraception].

Authors:  I Lete Lasa; M Arróniz; R Esquisábel
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

2.  Emergency contraception. Summary of the Society of Obstetricians and Gynaecologists of Canada's clinical practice guidelines.

Authors:  S Dunn; V Davis
Journal:  Can Fam Physician       Date:  2001-06       Impact factor: 3.275

Review 3.  Emergency contraception: a review of current oral options.

Authors:  Marisa N Mendez
Journal:  West J Med       Date:  2002-05

4.  How safe is emergency contraception?

Authors:  Abigail Norris Turner; Charlotte Ellertson
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 5.  Ectopic pregnancy and emergency contraceptive pills: a systematic review.

Authors:  Kelly Cleland; Elizabeth Raymond; James Trussell; Linan Cheng; Haoping Zhu
Journal:  Obstet Gynecol       Date:  2010-06       Impact factor: 7.661

6.  Emergency contraceptive options available for adolescents.

Authors:  Vishal Gupta; Ran D Goldman
Journal:  Can Fam Physician       Date:  2006-10       Impact factor: 3.275

7.  Hormonal contraception--what kind, when, and for whom?

Authors:  Inka Wiegratz; Christian J Thaler
Journal:  Dtsch Arztebl Int       Date:  2011-07-18       Impact factor: 5.594

8.  Pharmacy students' knowledge, attitudes, and behaviors regarding emergency contraception.

Authors:  Denise Ragland; Donna West
Journal:  Am J Pharm Educ       Date:  2009-04-07       Impact factor: 2.047

Review 9.  A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive.

Authors:  Nattawut Leelakanok; Janthima Methaneethorn
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

10.  Progesterone receptor modulator for emergency contraception: a randomized controlled trial.

Authors:  Mitchell D Creinin; William Schlaff; David F Archer; Livia Wan; Ron Frezieres; Michael Thomas; Michael Rosenberg; James Higgins
Journal:  Obstet Gynecol       Date:  2006-11       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.